Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO)
Morocco
· Delayed Price · Currency is MAD 910.00
0.00 (0.00%)
At close: Dec 24, 2024
CBSE: PRO Income Statement
Financials in millions MAD. Fiscal year is January - December.
Millions MAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 805.52 | 805.52 | 704.64 | 630.49 | 573.2 | 522.45 | Upgrade
|
| Revenue Growth (YoY) | 14.32% | 14.32% | 11.76% | 10.00% | 9.71% | 17.53% | Upgrade
|
| Cost of Revenue | 446.27 | 446.27 | 332.17 | 299.96 | 272.81 | 263.45 | Upgrade
|
| Gross Profit | 359.24 | 359.24 | 372.47 | 330.53 | 300.38 | 259 | Upgrade
|
| Selling, General & Admin | 235.94 | 235.94 | 209.75 | 197.83 | 174.68 | 155 | Upgrade
|
| Other Operating Expenses | 22.64 | 22.64 | 28.6 | 27.77 | 24.22 | 12.76 | Upgrade
|
| Operating Expenses | 270.6 | 270.6 | 247.48 | 225.61 | 198.9 | 167.76 | Upgrade
|
| Operating Income | 88.65 | 88.65 | 124.98 | 104.92 | 101.48 | 91.24 | Upgrade
|
| Interest Expense | -4.64 | -4.64 | -1.42 | -0.31 | -0.09 | -1.28 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | 0.86 | 0.5 | 0.55 | 0.47 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.94 | 2.94 | -9.92 | 1.35 | -0.3 | -1.63 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.21 | 0.21 | -1.5 | 0.17 | -1.07 | 0.82 | Upgrade
|
| EBT Excluding Unusual Items | 87.19 | 87.19 | 113.01 | 106.63 | 100.57 | 89.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.23 | 0.23 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.2 | 0.2 | 1 | 0.03 | -0.01 | -0.16 | Upgrade
|
| Other Unusual Items | 0.17 | 0.17 | 0.25 | -3.97 | -10.12 | -7.87 | Upgrade
|
| Pretax Income | 87.79 | 87.79 | 114.25 | 102.69 | 90.45 | 81.58 | Upgrade
|
| Income Tax Expense | 30.9 | 30.9 | 38.97 | 33.72 | 30.19 | 29.47 | Upgrade
|
| Net Income | 56.9 | 56.9 | 75.28 | 68.97 | 60.26 | 52.11 | Upgrade
|
| Net Income to Common | 56.9 | 56.9 | 75.28 | 68.97 | 60.26 | 52.11 | Upgrade
|
| Net Income Growth | -24.42% | -24.42% | 9.15% | 14.45% | 15.63% | 34.50% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| EPS (Basic) | 56.90 | 56.90 | 75.28 | 68.97 | 60.26 | 52.11 | Upgrade
|
| EPS (Diluted) | 56.90 | 56.90 | 75.28 | 68.97 | 60.26 | 52.11 | Upgrade
|
| EPS Growth | -24.42% | -24.42% | 9.15% | 14.45% | 15.63% | 34.50% | Upgrade
|
| Free Cash Flow | -3.63 | -3.63 | 70.32 | 215.53 | - | - | Upgrade
|
| Free Cash Flow Per Share | -3.63 | -3.63 | 70.32 | 215.53 | - | - | Upgrade
|
| Dividend Per Share | - | - | 40.000 | 40.000 | - | - | Upgrade
|
| Gross Margin | 44.60% | 44.60% | 52.86% | 52.42% | 52.41% | 49.57% | Upgrade
|
| Operating Margin | 11.00% | 11.00% | 17.74% | 16.64% | 17.70% | 17.46% | Upgrade
|
| Profit Margin | 7.06% | 7.06% | 10.68% | 10.94% | 10.51% | 9.97% | Upgrade
|
| Free Cash Flow Margin | -0.45% | -0.45% | 9.98% | 34.18% | - | - | Upgrade
|
| EBITDA | 100.66 | 100.66 | 134.12 | - | - | - | Upgrade
|
| EBITDA Margin | 12.50% | 12.50% | 19.03% | - | - | - | Upgrade
|
| D&A For EBITDA | 12.02 | 12.02 | 9.13 | - | - | - | Upgrade
|
| EBIT | 88.65 | 88.65 | 124.98 | 104.92 | 101.48 | 91.24 | Upgrade
|
| EBIT Margin | 11.00% | 11.00% | 17.74% | 16.64% | 17.70% | 17.46% | Upgrade
|
| Effective Tax Rate | 35.19% | 35.19% | 34.11% | 32.84% | 33.38% | 36.12% | Upgrade
|
| Revenue as Reported | 844.21 | 844.21 | 746.77 | 631.59 | 637.96 | 529.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.